BioLineRx Ltd. (BLRX)
$2.22+0.45%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10M
- Beta
- 0.70
- P/E (TTM)
- -1.27
- Short % float
- 3.50%
- Days to cover
- 11.1
- SI change
- -0.2%
- 1W
- -6.33%
- 1M
- -13.62%
- vs SPY 1W
- -7.49%
- vs SPY 1M
- -16.61%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BLRX?
- LOPJLB’s latest quantitative signal on BioLineRx Ltd. (BLRX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BLRX in?
- BioLineRx Ltd. (BLRX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does BioLineRx Ltd. (BLRX) do?
- BioLineRx Ltd., an Israeli biopharmaceutical firm established in 2003 and based in Hevel Modi'in, focuses its clinical-stage development efforts primarily on oncology. Their leading investigational product, Motixafortide, a peptide, has successfully concluded pivotal Phase 3 clinical trials for mobilizing stem cells in autologous transplants, and Phase 2a trials targeting pancreatic cancer. Thi…